A Novel Braided Stent With Customized Simulation Software for Treatment of Intracranial Aneurysms: Multicenter Prospective Trial Before Unrestricted Clinical Application

Author:

Kan Issei1ORCID,Oishi Hidenori2,Hyodo Akio3,Nemoto Shigeru4,Fujimura Soichiro56,Ishibashi Toshihiro1,Sumita Kazutaka4,Takigawa Tomoji3,Teranishi Kohsuke2,Kodama Tomonobu1,Kato Naoki1,Takao Hiroyuki16,Murayama Yuichi1

Affiliation:

1. Department of Neurosurgery, The Jikei University School of Medicine, Tokyo, Japan;

2. Department of Neuroendovascular Therapy and Neurosurgery, Juntendo University Faculty of Medicine, Tokyo, Japan;

3. Department of Neurosurgery, Dokkyo Medical University Saitama Medical Center, Saitama, Japan;

4. Department of Endovascular surgery, Tokyo Medical and Dental University, Tokyo, Japan;

5. Department of Mechanical Engineering, Tokyo University of Science, Tokyo, Japan;

6. Division of Innovation for Medical Information Technology, Jikei University School of Medicine, Tokyo, Japan

Abstract

BACKGROUND AND OBJECTIVES: Planning/guidance software became important tools for physicians' presurgical optimal decision-making. However, there are no intracranial stent products with specifically associated simulation software. We report the “premarket” clinical trial of a new braided stent with a customized simulation software. METHODS: A stent system with 3 mesh density types (16, 24, and 32 wire mesh) was designed based on computational flow dynamics technology, and a simulation software (virtual stent planner [VSP]) was developed for the optimal stent deployment planning. Stents were selected after simulation on preoperative 3D-processed angioimages, and accuracy of the VSP was evaluated. RESULTS: Thirty-three unruptured intracranial aneurysms were successfully treated with VSP guidance. Twenty aneurysms (61%) were anterior circulation aneurysms, and 13 (39%) were posterior circulation aneurysms. The average aneurysm size was 7.1 mm, and the mean follow-up period was 19.2 months (11-39.0). There was no major recurrence or retreatment during follow-up, 2 morbidity cases, and no mortality. VSP planning presented slightly smaller stent dimensions compared with postdeployment: 24.2 vs 25.5 mm average, error —1.3 mm, and difference rate—5.46%. CONCLUSION: Based on this result, the new stents and software guidance system were approved by the Ministry of Health and Welfare as a combined medical device. VSP provided precise deployment with minimal error compared with actual stent and can contribute to better stent deployment even for less experienced physicians.

Funder

Japan Agency for Medical Research and Development

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3